亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Conditional Risk and Predictive Factors Associated with Late Toxicity for Prostate Cancer Patients Treated with External Beam Radiotherapy Alone on Randomized Trial RTOG 0126

前列腺癌 放射治疗 外照射放疗 医学 随机对照试验 肿瘤科 毒性 内科学 癌症
作者
Gregory S. Alexander,R.F. Krc,J.W. Assif,Kai Sun,Jason K. Molitoris,Phuoc T. Tran,Zaker Rana,Mark V. Mishra
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
标识
DOI:10.1016/j.ijrobp.2024.05.023
摘要

Purpose The objective of this study was to characterize the conditional risk of developing a grade 2+ urinary or gastrointestinal toxicity for patients treated with external beam radiotherapy on RTOG 0126. A secondary objective was to analyze baseline patient and treatment characteristics and determine their relevance in predicting toxicity both at the time of trial enrollment and later points of follow up. Methods and Materials 1,532 patients with localized prostate cancer were enrolled between March 2002 and August 2008, of whom 1,499 were eligible and included in data analysis with a median follow up of 8.4 years (range 0.02-13). Patients were treated with either 3DCRT or IMRT according to institutional practice without the addition of androgen deprivation and randomized to receive either standard dose radiotherapy of 70.2 Gy or dose escalated radiotherapy of 79.2 Gy of radiotherapy to the prostate only with standard fractionation. UVA and MVA analyses were determine if initial factors were predictive of late toxicity at time of treatment and at later timepoints. Results As patients proceed further from completion of radiotherapy without the development of toxicity, the subsequent risk of both grade 2+ GU and GI toxicity decreased with time. At time of enrollment the risk of developing a grade 2+ toxicity over the next 5 years was 9.57 and 17.89% respectively. After five years of toxicity free survival, the risk of developing a grade 2+ GU or GI toxicity in the subsequent five years was 3.02% and 1.54% respectively. Baseline treatment and patient related factors predicted late toxicity both at trial enrollment and after two years of toxicity free survivorship. Baseline urinary dysfunction and dose escalated radiotherapy were associated with increased late GU toxicity. Acute GI toxicity and dose escalated radiotherapy were associated with increased risk of late GI toxicity. Treatment with IMRT was associated with reduced risk of either toxicity. Conclusions The conditional risk of grade 2+ toxicities decrease as patients proceed further from treatment with most toxicities occurring in the first few years after treatment completion. Baseline patient and treatment characteristics remain relevant at both enrollment and later time points. The objective of this study was to characterize the conditional risk of developing a grade 2+ urinary or gastrointestinal toxicity for patients treated with external beam radiotherapy on RTOG 0126. A secondary objective was to analyze baseline patient and treatment characteristics and determine their relevance in predicting toxicity both at the time of trial enrollment and later points of follow up. 1,532 patients with localized prostate cancer were enrolled between March 2002 and August 2008, of whom 1,499 were eligible and included in data analysis with a median follow up of 8.4 years (range 0.02-13). Patients were treated with either 3DCRT or IMRT according to institutional practice without the addition of androgen deprivation and randomized to receive either standard dose radiotherapy of 70.2 Gy or dose escalated radiotherapy of 79.2 Gy of radiotherapy to the prostate only with standard fractionation. UVA and MVA analyses were determine if initial factors were predictive of late toxicity at time of treatment and at later timepoints. As patients proceed further from completion of radiotherapy without the development of toxicity, the subsequent risk of both grade 2+ GU and GI toxicity decreased with time. At time of enrollment the risk of developing a grade 2+ toxicity over the next 5 years was 9.57 and 17.89% respectively. After five years of toxicity free survival, the risk of developing a grade 2+ GU or GI toxicity in the subsequent five years was 3.02% and 1.54% respectively. Baseline treatment and patient related factors predicted late toxicity both at trial enrollment and after two years of toxicity free survivorship. Baseline urinary dysfunction and dose escalated radiotherapy were associated with increased late GU toxicity. Acute GI toxicity and dose escalated radiotherapy were associated with increased risk of late GI toxicity. Treatment with IMRT was associated with reduced risk of either toxicity. The conditional risk of grade 2+ toxicities decrease as patients proceed further from treatment with most toxicities occurring in the first few years after treatment completion. Baseline patient and treatment characteristics remain relevant at both enrollment and later time points.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
清新的雨文完成签到,获得积分10
4秒前
ZZWZHENG发布了新的文献求助50
5秒前
13秒前
14秒前
爱笑歌曲完成签到,获得积分10
22秒前
FG完成签到 ,获得积分10
32秒前
34秒前
标致的元蝶完成签到,获得积分10
51秒前
科研通AI6.4的应助被葛力采纳,获得10
52秒前
神勇凡英完成签到,获得积分10
1分钟前
1分钟前
彭于晏的应助被敏感寻真采纳,获得10
1分钟前
要减肥的菀完成签到,获得积分10
1分钟前
淡淡傲柔完成签到,获得积分10
1分钟前
1分钟前
敏感寻真发布了新的文献求助10
1分钟前
葛力发布了新的文献求助10
1分钟前
parantal发布了新的文献求助10
1分钟前
大模型的应助被科研通管家采纳,获得10
1分钟前
结实的易真完成签到,获得积分10
1分钟前
姜OMG发布了新的文献求助10
1分钟前
葛力完成签到,获得积分10
1分钟前
姜OMG完成签到,获得积分10
2分钟前
2分钟前
taku完成签到 ,获得积分10
2分钟前
灵剑山发布了新的文献求助10
2分钟前
称心的忆山完成签到,获得积分10
2分钟前
parantal发布了新的文献求助30
2分钟前
深情的飞烟完成签到,获得积分10
2分钟前
2分钟前
细腻伯云完成签到,获得积分10
3分钟前
大气钧完成签到,获得积分10
3分钟前
3分钟前
3分钟前
3分钟前
风吹麦浪的应助被科研通管家采纳,获得10
3分钟前
威武的碧玉完成签到,获得积分10
3分钟前
忧郁凝阳完成签到,获得积分10
4分钟前
欢喜的小蕾完成签到,获得积分10
4分钟前
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173069
求助须知:如何正确求助?哪些是违规求助? 9565519
关于积分的说明 21780407
捐赠科研通 7765088
什么是DOI,文献DOI怎么找? 3431532
关于科研通互助平台的介绍 2555638
邀请新用户注册赠送积分活动 2476668